Arkolith/Insider Trading/AVDL/Form 4

Palczuk Linda

DirectorAVADEL PHARMACEUTICALS PLC (AVDL) · full profile →Form 4 · filed Dec 10, 2024
Net Buying
Open-Market Buys
$31K
Open-Market Sells
$0
Net Open-Market Flow
$31K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 6, 2024Buy(P)3K$10.19$31K66K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-24-126999) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML